Funding
← Back to your selection

Regeneron Ventures

Activity from announced rounds

Activity in this selectionSeries A
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$130M
2 disclosed · full round size, not this investor’s share

By stage

Series A2

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
Infinimmune

Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease

$75MSeries A
Role not disclosed
Think Bioscience

Develops small molecule drugs for historically challenging drug targets

$55MSeries A
Role not disclosed